Question

India's largest and first multi-national pharmaceutical giant Ranbaxy is being bought over by ____.

• A. Matrix Pharma.
• B. GVK Bio-sciences.
• C. Merck.
• D. None of these.

Hint:

The real buyer was a Japanese pharma company, not any of the first three names given.

Answer 1

The Correct Option is D

This question checks whether the student remembers a major corporate news event from 2008, when Ranbaxy Laboratories, India's largest and first true multinational pharmaceutical company, changed hands.

1. Matrix Pharma: Matrix Laboratories was an Indian drug maker that was later bought by the American company Mylan, but it had no part in the Ranbaxy deal, so this option is wrong.
2. GVK Bio-sciences: GVK Biosciences works in contract research and clinical trials. It never made a bid for Ranbaxy, so this option does not fit.
3. Merck: Merck is a well known global pharma company, but it was not the buyer in this case, so this option is also wrong.
4. None of these: The real buyer was Daiichi Sankyo, a Japanese pharmaceutical company. In June 2008, the Singh family, who founded and controlled Ranbaxy, sold their stake to Daiichi Sankyo, giving it a controlling share of nearly 64 percent in the company.

Since Daiichi Sankyo does not appear among the first three named companies, the correct choice has to be option 4, None of these.

Let's summarize:

• Ranbaxy was India's largest and first multinational pharma company.
• The Singh family sold their controlling stake to Daiichi Sankyo of Japan in 2008.
• None of the three companies listed in the question matches the actual buyer.

The correct answer is option 4, None of these.